Joint-Wit Medical & Pharmaceutical Industry And SU BioMedicine To Set Up Joint Venture
This article was originally published in PharmAsia News
Executive Summary
Sichuan Joint-Wit Medical & Pharmaceutical Industry and Netherlands-based SU BioMedicine will each invest RMB 5 million to set up a 50:50 joint venture, which will operate businesses such as herbal medicine, TCM, food additive R&D, marketing, as well as Chinese medicine intermediates production. SU BioMedicine, a subsidiary of the Netherlands Organization for Applied Scientific Research, currently collaborates with many Chinese research institutions and enterprises to develop plant medicine for metabolism syndrome. The tie-up will improve Joint-Wit's international competitiveness through the introduction of advanced pharmaceutical techniques. The joint company will establish a GMP-compliant production line within existing Joint-Wit facilities to produce plant medicine and food addictives, to be developed into plant or natural medicine for the EU and U.S. markets. (Click here for more - Chinese Language)